Narrow search
Showing 1 - 10 of 37,383
Cover Image
Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness
Prosser, Lisa A.; O'Brien, Megan A.; Molinari, … - In: PharmacoEconomics 26 (2008) 2, pp. 163-178
non-traditional settings such as worksites and pharmacies may be a way to enhance vaccination coverage for adults, but … benefits, costs and cost effectiveness of delivering influenza vaccination to adults of varying ages and risk groups in non … for healthy adults aged >=50 years, and for high-risk adults of all ages. For healthy adults aged 18-49 years, preventing …
Persistent link: https://www.econbiz.de/10005243115
Cover Image
Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data
Lynd, Larry D.; Goeree, Ron; O'Brien, Bernie J. - In: PharmacoEconomics 23 (2005) 11, pp. 1083-1106
following rapid influenza testing. Study populations included healthy adults, adults at risk of influenza-related adverse …
Persistent link: https://www.econbiz.de/10005243143
Cover Image
Economic Evaluations of Childhood Influenza Vaccination: A Critical Review
Newall, Anthony T.; Jit, Mark; Beutels, Philippe - In: PharmacoEconomics 30 (2012) 8, pp. 647-660
The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were...
Persistent link: https://www.econbiz.de/10010556696
Cover Image
Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination
Pradas-Velasco, Roberto; Antonanzas-Villar, Fernando; … - In: PharmacoEconomics 26 (2008) 1, pp. 45-56
Objective: To evaluate the economic efficiency of influenza vaccination using both dynamic and static modelling approaches. Setting: The Spanish National Health System. Design and methods: We modelled the progress of an influenza epidemic in Spain according to the epidemiological pattern of...
Persistent link: https://www.econbiz.de/10005243208
Cover Image
Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer
At'kov, O. Yu. Atkov; Azarov, A.V.; Zhukov, D.A.; … - In: Applied Health Economics and Health Policy 9 (2011) 2, pp. 89-99
. Influenza infection of healthy working adults can have a marked effect on companies due to lost work days and reduced … adults in Russia and the economic benefits of such a programme from an employer's perspective. Methods: In a prospective, non …-randomized, non-placebo-controlled, observational study, healthy vaccinated and unvaccinated adults employed at the Russian Railways …
Persistent link: https://www.econbiz.de/10010614270
Cover Image
Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study
Pisu, Maria; Meltzer, Martin I.; Hurwitz, Eugene S.; … - In: PharmacoEconomics 23 (2005) 1, pp. 55-67
Background: Vaccinating children against influenza virus may reduce infections in immunised children and household contacts, thereby reducing the household-based cost associated with respiratory illnesses. Objective: To evaluate the impact of influenza virus vaccination of daycare children on...
Persistent link: https://www.econbiz.de/10005404931
Cover Image
Economic Impact of Providing Workplace Influenza Vaccination: A Model and Case Study Application at a Brazilian Pharma-Chemical Company
Burckel, Emmanuel; Ashraf, Talat; Galvao de Sousa … - In: PharmacoEconomics 16 (1999) 5, pp. 563-576
Objective: To develop and apply a model to assess the economic value of a workplace influenza programme from the perspective of the employer. Design: The model calculated the avoided costs of influenza, including treatment costs, lost productivity, lost worker added value and the cost of...
Persistent link: https://www.econbiz.de/10005404933
Cover Image
Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK
Sander, Beate; Hayden, Frederick G.; Gyldmark, Marlene; … - In: PharmacoEconomics 24 (2006) 4, pp. 373-386
Objectives: To assess the cost effectiveness and cost utility of preventing post-exposure influenza infection using the neuraminidase inhibitor oseltamivir from a healthcare payer's perspective in the UK. Methods: A simulation model was developed, based on clinical trial results and published...
Persistent link: https://www.econbiz.de/10005449022
Cover Image
Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
Soares, Marta O.; Canto e Castro, Lusa - In: PharmacoEconomics 30 (2012) 12, pp. 1101-1117
The design of decision-analytic models for cost-effectiveness analysis has been the subject of discussion. The current work addresses this issue by noting that, when time is to be explicitly modelled, we need to represent phenomena occurring in continuous time. Models evaluated in continuous...
Persistent link: https://www.econbiz.de/10011005076
Cover Image
Population- versus Cohort-Based Modelling Approaches
Ethgen, Olivier; Standaert, Baudouin - In: PharmacoEconomics 30 (2012) 3, pp. 171-181
While no single type of model can provide adequate answers under all circumstances, any modelling endeavour should incorporate three fundamental considerations in any decision-making question: the target population, the disease and the intervention characteristics. A target population is likely...
Persistent link: https://www.econbiz.de/10009493378